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Acute Burkitt's Leukemia: Case Report and Literature Review 
S. Raman, MD,* S. M. Saeed, MD,* and K. R. Kini, MD** 
The occurrence of leukemia in Burkitt's lymphoma, with or 
without visceral or nodal tumefacdon is uncommon, and 
its inidal presentation as leukemia is even more unusual. 
Because it has a poor chemotherapeutic response and a 
grave prognosis, it is important to recognize this unusual 
leukemia correctly. Our report describes the clinical and 
pathologic findings of Burkitt's lymphoma cell leukemia in 
a five-year-old white boy who presented with abdominal 
distension, hepatosplenomegaly, and lymphadenopathy. 
Blood examinadon revealed normocydc normochromic 
anemia, erythroblastosis, slight leukocytosis, and the pres-
ence of numerous (24%) blasts. A diagnosis of Burkitt's 
lymphoma was established on the basis of morphologic, 
cytochemical, and immunologic studies performed on the 
blasts. When the chemotherapy protocol for the lymphoma 
was administered, the patient responded well initially but 
suffered uric acid nephropathy, which was successfully 
treated. However, within two weeks he had a rapid relapse 
of leukemia and died four months after admission. 
B urkitt's lymphoma is a bone tumor of the jaw usually 
found in Africa (1,2). Although ft has been known to 
involve organs other than the jaw, the incidence of bone 
marrow involvement is still not as common as with other 
non-Hodgkin's lymphomas (3). In the American variety of 
Burkitt's lymphoma, bone marrow involvement has been 
reported in 8% to 30% of cases (4-6). In rare instances, 
leukemia may occur during the course of the disease, 
usually as a terminal event. 
Very few cases have been reported in which this disease 
presented initially as true leukemia (7-12), and fewer have 
been studied in detail (8,10). We report such a case of 
leukemia with its characteristic clinical, histologic, and 
immunological features. 
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Case Report 
A five-year-old white boy was admitted with complaints of 
abdominal pain associated wfth increasing abdominal dis-
tention and vomiting that had lasted forone week. His past 
medical history and family history were unremarkable. 
Physical examination revealed a pale child with gener-
alized lymphadenopathy. Chest examination revealed de-
creased breath sounds and dullness to percussion in both 
bases. The heart rate was 150/min with regular rhythm. 
Blood pressure was 120/60. His abdomen was distended 
with a prominent fluid wave. Spleen was enlarged to 4 cm 
below the left costal margin, and the liver was palpable at 
the right costal margin. 
The laboratory findings were hemoglobin 10.5 gm%, hem-
atocrit 32.3%, white cell count 19,600 x ^ 0 \ platelets 
286,000/mm3, white cell differential count 44% PMNs, 8% 
bands, 4% metamyelocytes, 3% myelocytes, 2% prom-
yelocytes, 5% monocytes, 10% lymphocytes, and 24% 
blasts with basophilic cytoplasm containing multiple vac-
uoles (Fig. 1). The only other abnormal laboratory findings 
at this time were an elevated serum lactic dehydrogenase 
(LDH) of 2,480 U/L and an increased erythrocyte sedimen-
tation rate of 22 mm/hr. 
The chest radiograph revealed bilateral pleural effusion. A 
computerized axial tomogram of the abdomen demon-
strated enlarged lymph nodes along the aorta and a mass in 
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the area of the terminal ileum. Also seen was right-sided 
hydronephrosis, possibly secondary to partial obstruction 
at the ureteropelvic junction. 
A biopsy of the supraclavicular lymph node was per-
formed, and when the specimen was stained ( H & E stain) 
and examined, partial effacement of normal lymphoid 
architecture was seen due to a monotonous but "starry 
Fig. 1: Left 
Burkitt's leukemia cell in peripheral blood smear. Leishman stain 
(1000X). 
Fig. 2: Right 
Sectk>n of lymph node involved by the neoplasm showing characteristic 
starry sky pattem. H & E stain (63X). 
sky" infiltrate composed of undifferentiated blast cells and 
phagocytic, benign histiocytes (Figs. 2,3). In the imprints 
the blasts had fairly round, noncleaved nuclei surrounded 
by a rim of deeply basophilic and vacuolated cytoplasm 
(Fig. 4). The nuclear chromatin was fine with two to four 
small to medium-sized nucleoli. The cells produced signifi-
cant pyroninophilia with methyl green pyronin stain and 
stained negatively with para-aminosalicylic acid (PAS). An 
iliac bone marrow aspirate (Fig. 5) and biopsy indicated 
massive infiltration of the marrow by the undifferentiated 
blasts. Thoracentesis yielded serosanguinous fluid, with 
35% lymphoblasts. Cerebrospinal f lu id analysis was 
nondiagnostic. 
Fig. 5 
Bone marrow smear showing extensive infiltration with Burkitt's tumor 
cells. Leishman stain (1000X). 
Fig. 3: Left 
Higher magnificatbn of lymph node section showing monomorphic 
populatbn of undifferentiated blasts interspersed with benign phagocy-
tic histiocytes. H & E stain (400X). 
Fig. 4: Right 
Imprints from lymph node showing Burkitt's tumor cells. Leishman stain 
(1000X). 
On the basis of the above findings, acute Burkitt's lym-
phoma cell leukemia was diagnosed. A modified LSA2L2 
protocol for pediatric lymphomas was prescribed for the 
patient, and chemotherapy was initiated with Cytoxan 
(1200 mgm/M2 IV on day 1), vincristine (1.5 mgm/M2 IV 
weekly times four doses), prednisone (60 mgm/M2 in four 
divided doses for 28 days), methotrexate (6.25 mgm/M2 IT 
weekly times four doses), and daunomyecin (60 mgm/M2 
IV on two successive days between the second and third 
vincristine injections). He also received allopurinol. How-
ever, when the boy's blood urea nitrogen (90 mg/dl) and 
uric acid (21 mg/dl) became markedly elevated, it was 
apparent that he was developing uric acid nephropathy and 
renal failure due to the rapid breakdown of his tumor. He 
was also hypertensive and developed alpha streptococcal 
septicemia. The uric acid nephropathy was successfully 
treated with intravenous fluids, allopurinol, diamox, and 
alkalinization of urine. His hypertension was controlled 
we l l w i t h th iazide and apr izol ine. T icarc i l l in and to-
bramycin were instituted to treat the sepsis. He was dis-
charged on maintenance doses of prednisone. 
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TABLE I 
Clinical and Laboratory Features of 
Cases Diagnosed as Acute Burkitt's Cell Leukemia 
Case Age Sex 
Presenting 
Features 
Lymph 
Nodes Spleen Liver Other 
Bone 
Marrow 
Morphology 
Hb 
G/dl 
WBC Count 
with % 
Blasts in Cell 
Peripheral Marker 
Blood Studies 
Abnormal 
Bio- E.B. 
chemical Virus 
Findings Studies 
17 
2(8) M 
319, 14 M 
14 
5(11) 
6(12) 
M 
121/2 F 
15 
8 
our 
M 
Hematuria, 
Nuchal ache, 
Weight loss, 
Abdominal, 
chest pain 
Swelling 
cheeks, 
proptosis, 
bleeding from 
gums, in 
stools 
Neck 
swelling, 
pain in 
jaw witti 
loosening of 
teeth, 
bleeding gums 
Fever, 
abdominal 
pain 
Anorexia, 
anemia, 
abdominal 
swelling 
and pain 
Acute 
abdominal 
pain 
Fever, 
facial 
swelling, 
bleeding gums 
Vomiting, 
abdominal 
pain 
- H -
-F-F 
+ — 
-n - Facial 
swelling 
+ + 
Tumor, 
left 
upper lid 
90% 
blasts 
100% 
blasts 
Sheets of 
blasts 
10 
4,5 
7.2 
+ Petechiae, 88% 
enlarged blasts 
ovary 
Involved 
by lymph-
oma 
-F-l- Abdominal 100% 
masses blasts 
Lympho-
matous 
tumor In 
ileum, 
mesen-
tery 
Breast 
masses, 
maxillary 
swelling, 
proptosis 
Mass in 
terminal 
ileum, 
ureter; 
pleural 
effusion 
Massive 
infiltra-
tion with 
blast 
cells 
Massive 
Infiltra-
tion with 
blast 
cells 
100% 
blasts 
10.2 
9-5 
WBC 
27000/mm3 
Blasts, 65% 
WBC 
59,700/dl 
Numerous 
blasts 
WBC 
5800/mm3 
scanty 
blasts 
WBC 
14,200/mm3 
Blasts, 22% 
WBC 
25,299/ul 
Blasts, 9% 
not 
done 
not 
done 
not 
done 
Sugges-
tive of 
non-B 
non-T 
possi-
bly null 
not 
done 
12.5 WBC IgM 
16,700/mm3 kappa 
Blasts, 30% in 60% 
of 
blasts 
12 WBC IgM 
33,000/mm3 kappa 
Blasts, 80% in 90% 
of 
blasts 
10.5 WBC 
19,600 X I 0 ^ 
Blasts, 24% 
to 50% 
IgM 
kappa, 
igD 
LDH, 
SCOT 
BUN, 
Uric acid 
Unremarl<-
able 
Not 
elevated 
BUN Not 
done 
SCOT, Elevated 
LDH, 
BUN, 
Uric acid 
Uric acid. Not 
total done 
protein 
Uric acid. Normal 
SCOT, 
alkaline 
phosph-
atase 
LDH 
LDH 
Normal 
Normal 
When the patient was discharged, his serum LDH was 11 
U/L. Both uric acid and blood urea nitrogen were normal, 
and no blasts were seen in the peripheral blood smear. His 
abdominal girth was significantly reduced; a CAT scan of 
the abdomen demonstrated a marked reduction in the size 
of periaortic and ileocecal masses. A repeat bone marrow 
aspirate showed slight hypoplasia but no tumor. However, 
within two weeks of the patient's discharge, the peripheral 
blood examination revealed 50% blasts. Immunological 
marker studies indicated that monoclonal membrane-
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Case Chemotherapy 
TABLE II 
Response to Therapy and Prognosis In Cases 
Diagnosed as Acute Burkitt's Cell Leukemia 
Initial 
Response 
to Therapy 
Duration 
of Remission 
Mode 
of 
Relapse 
Length 
of Survival 
Terminal 
Autopsy Findings 
1'^' Vincristine, 
prednisone 
2"" Vincristine, 
cyclophosphamide 
prednisone 
3'" Cyclophosphamide 
Cyclophosphamide 
5'"' Vincristine, 
methotrexate, 
prednisolone 
6"^' Cyclophosphamide, 
vincristine, 
prednisone, 
methotrexate 
(intrathecal) 
7"^' Cyclophosphamide, 
vincristine, 
prednisone, 
methotrexate 
8 Cytoxan, 
our vincristine, 
case prednisone, 
methotrexate 
(intrathecal) 
Dramatic and 
complete 
Poor, died four 
days after 
admission 
Complete 
remission 
Complete 
remission 
Complete 
remission 
Complete 
remission 
Complete 
remission 
Complete 
remission 
About 1 week 
20 days 
6 months 
3 weeks 
3 weeks 
4 weeks 
1 month 
Blood and marrow 
CNS 
(positive CSF) 
Blood and marrow 
Blood and marrow 
Blood and marrow 
Meningeal 
Meningeal 
leukemia 
Blood and marrow 
3 months Massive hemorrhage, sepsis, 
generalized leukemic 
infiltrate 
4 days Neoplastic involvement of 
jaws, orbits, marrow, 
liver, spleen, Gl tract, 
lymph nodes 
4 months Extensive marrow involve-
ment with hepatospleno-
megaly, lymphadeno-
pathy 
7V2 months Sepsis, internal hemor-
rhage, renal failure; 
extensive neoplastic 
infiltrate in marrow and 
abdominal viscera 
3 weeks Leukopenia, bronchopneu-
monia 
6 months Marrow and meningeal 
involvement, neutropenia 
and E. coli sepsis 
I Imon ths Diffuse neoplastic 
involvement of CNS 
4 months Massive marrow involve-
ment by neoplasm, pneu-
monia, severe thrombo-
cytopenia 
bound IgM (kappa) immunoglobulin was present on 88% 
and IgD was present on 65% ofthe blasts. The patient was 
hospitalized again for chemotherapy, but he developed 
pneumonia as well as persistent thrombocytopenia that 
required several platelet transfusions. In spite of vigorous 
chemotherapy and supportive measures, his condition be-
came worse, and he died four months after his disease had 
been first diagnosed. An autopsy was not performed. 
Discussion 
Burkitt's lymphoma is a well-defined neoplasm (1,2) and 
both African (2) and American (3,5) varieties have been 
studied. In the American subtype, extensive bone marrow 
involvement is more common (4-6), although leukemia as 
a terminal phase is not common (4,5,13). Leukemia is not 
commonly the initial presenting event, and most such 
reports have originated outside the United States. Since 
Stevens, et al reported a case of Burkitt's cell leukemia in 
1972 (7), only a few addftional cases with the initial 
leukemic component have been reported (7-12). It is well 
recognized that almost 3% of the acute lymphoblastic 
leukemia cells have B-cell immunologic markers and pos-
sess cytoplasmic pyroninophilia and vacuolization. These 
patients do not have visceral and/or soft tissue involvement 
like that seen in Burkitt's lymphoma. Therefore, B-cell 
acute lymphocytic leukemia cases (14) should be separated 
from cases which have typical clinical and pathologic 
findings of Burkitt's lymphoma with a presenting leukemic 
component. 
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The reported cases of Burkitt's leukemia (Tables I and 11) are 
similar to the non-African and American Burkitt's lympho-
mas in their characteristic clinical presentation and multi-
ple organ involvements. Abdominal organ involvement 
was most frequent. But unlike the lymphomas, seven of 
eight cases of leukemia presented with varying degrees of 
generalized lymphadenopathy. Bone marrow involvement 
in all cases was always massive, and the peripheral white 
cell count in most instances was significantly elevated. 
Chemotherapy produced a dramatic initial response in all 
cases except for one patient who lived only four days after 
admission. However, the remission in all cases was short-
lived wfth relapse of leukemia and rapid death. The pa-
tients survived after relapse usually less than six months. 
Terminal or autopsy findings in seven of eight patients 
included widespread neoplastic organ infiltrates with asso-
ciated sepsis and hemorrhage in some cases. The response 
and short survival ofthese patients is similar to that of most 
cases of American Burkitt's lymphoma where bone marrow 
was extensively involved. Epstein-Barr viral titers were 
usually normal or not significantly elevated in all but one 
patient (Tables I and 11). This finding supports the conten-
tion of some authors (15) that the Epstein-Barr virus titers 
may be less significant in non-African Burkitt's leukemia 
and lymphoma than in the African variety. 
Immunological studies have been performed in only a few 
cases of Burkitt's leukemia. In most cases, including ours, 
monoclonal surface immunoglobulins (usually IgM kappa) 
were consistently present. Presence of delta chains in our 
case is not surprising since these are produced by IgM-
bearing normal or neoplastic lymphoid cells (14,16). 
Cadman, et al (17) studied uric acid nephropathy that 
developed during effective chemotherapy in Burkitt's lym-
phoma and leukemia due to rapid cell lysis. As they 
indicated, a markedly elevated LDH forewarned us of this 
possibility, as did the clinically and morphologically exten-
sive neoplastic infiltrates in our patient. We were thus able 
to successfully treat this aspect of the disease. 
Conclusion 
Cases of acute Burkitt's leukemia differ from the typical 
cases of B-cell acute lymphocytic leukemia (B-ALL) with 
massive multi-organ involvement. The associated clinical 
and pathologic findings of Burkitt's lymphoma do not 
occur in cases of B-ALL, although extensive marrow in-
volvement, many blasts in the blood, and lymphadenopa-
thy are common accompaniments. Burkitt's leukemia may 
represent a particularly aggressive form of B-lymphoblast 
malignancy which shows sudden, massive tumefaction and 
leukemia that is difficult to control wfth the commonly 
employed chemotherapy for Burkitt's lymphoma or child-
hood ALL. The few cases in which detailed immunological 
studies on the tumor cells have been performed demon-
strated monoclonal B-cell markers. 
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